Literature DB >> 3131118

Characterization of prolactin-releasing factor in the rat posterior pituitary.

J F Hyde1, N Ben-Jonathan.   

Abstract

We previously reported that the rat posterior pituitary contains a potent PRL-releasing factor (PRF) which is distinct from oxytocin (OT), TRH, and angiotensin II (AII). The objectives of this study were 1) to examine whether posterior pituitary extracts stimulate PRL release in the presence of dopamine (DA), 2) to determine the chemical nature of PRF, and 3) to estimate its mol wt. Perifused anterior pituitary cells were used to assess PRF activity. Posterior pituitaries and medial basal hypothalamus (MBH) fragments were extracted with perchloric acid and lyophilized. Subsequent to various treatments, samples were reconstituted in the perifusion medium and introduced to the cells in short pulses. Fractions were collected and analyzed for hormone content by RIA. During a constant infusion of DA (50 nM), PRL secretion was inhibited by 75%, yet the posterior pituitary extract retained its ability to rapidly stimulate PRL release. Studies using proteolytic enzymes showed that posterior pituitary PRF was resistant to inactivation by trypsin, whereas the PRF activity of AII was abolished. Both chymotrypsin and proline-specific endopeptidase significantly reduced the PRF activity in the posterior pituitary. The PRL-releasing activity of TRH was not affected by chymotrypsin. Immunoreactive vasoactive intestinal polypeptide was undetectable in posterior pituitary extracts. Oxidation of posterior pituitary extracts with performic acid caused only a modest reduction of their PRF activity, while the ability of OT to stimulate PRL release as well as immunoreactive OT was abolished. Studies using ultrafiltration membranes showed that the PRF activity in the posterior pituitary was less than 5,000 mol wt. Furthermore, posterior pituitary PRF partitioned in nearly equal amounts across 1K membranes, as did AII and OT. In contrast, about 80% of the PRF activity in the MBH and all of the synthetic TRH passed through the 1K membranes. We conclude that 1) posterior pituitary PRF can stimulate PRL secretion from perifused anterior pituitary cells in the presence of physiological concentrations of DA; 2) PRF is a small peptide(s) of less than 5,000, and perhaps closer to 1,000, mol wt; 3) PRF is resistant to inactivation by trypsin and to oxidation by performic acid, but is hydrolyzed by both chymotrypsin and proline-specific endopeptidase; and 4) these data further distinguish posterior pituitary PRF from known PRL secretagogues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131118     DOI: 10.1210/endo-122-6-2533

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Pituitary portal plasma levels of oxytocin during the estrous cycle, lactation, and hyperprolactinemia.

Authors:  D K Sarkar; S A Frautschy; N Mitsugi
Journal:  Ann N Y Acad Sci       Date:  1992-06-12       Impact factor: 5.691

Review 2.  Control of prolactin secretion by excitatory amino acids.

Authors:  György M Nagy; Ibolya Bodnár; Zsuzsanna Bánky; Béla Halász
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

3.  Prolactin regulation by heparin-binding growth factors expressed in mouse pituitary cell lines.

Authors:  Robert Hnasko; Nira Ben-Jonathan
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

4.  Effect of posterior pituitary lobectomy on in vivo and in vitro secretion of prolactin in lactating rats.

Authors:  F Mena; D Aguayo; M Vigueras; A Quintanar-Stephano; G Perera; T Morales
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

5.  Regional mechanisms within anterior pituitary of lactating rats may regulate prolactin secretion.

Authors:  Nestor Diaz; Icnelia Huerta; Nephtali Marina; Nilda Navarro; Flavio Mena
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

6.  Gender-biased activity of the novel prolactin releasing peptides: comparison with thyrotropin releasing hormone reveals only pharmacologic effects.

Authors:  W K Samson; Z T Resch; T C Murphy; J K Chang
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.